These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 18525434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ, Clarke K.
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [Abstract] [Full Text] [Related]

  • 3. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C, Vij AS.
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ, Norton LL, Patel RA, Dooley MA.
    Arthritis Rheum; 2005 Oct 15; 53(5):732-9. PubMed ID: 16208664
    [Abstract] [Full Text] [Related]

  • 13. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.
    Arch Intern Med; 2007 Mar 26; 167(6):591-6. PubMed ID: 17389291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug 26; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucocorticoid-induced osteoporosis preventive care in rheumatology patients.
    Koller G, Katz S, Charrois TL, Ye C.
    Arch Osteoporos; 2019 Feb 05; 14(1):16. PubMed ID: 30723883
    [Abstract] [Full Text] [Related]

  • 19. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E, Walker-Bone K.
    QJM; 2008 Apr 05; 101(4):317-23. PubMed ID: 18270228
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.